ArticleBlood and lymphatic cancer : targets and therapy2019

Prognostic analysis of CD5 expression in double-hit diffuse large B-cell lymphoma and effectiveness comparison in patients treated with dose-adjusted EPOCH plus rituximab/R-CHOP regimens.

Fangwen Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.